Role of p53 in Cell Death and Cancers

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: closed (31 January 2021) | Viewed by 5184

Special Issue Editors


E-Mail Website
Guest Editor
School of Medicine, The Jikei University, Tokyo, Japan
Interests: tumor suppressor; cancer stem cells; signaling pathway; target therapy

E-Mail Website1 Website2
Guest Editor
Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan
Interests: cancer; cell cycle; cellular senescence; endoplasmic reticulum stress; molecular target drugs; p53; transcriptional regulation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Since the tumor suppressor gene p53 was discovered about 40 years ago, research is still ongoing by many cancer researchers in the world. p53 is one of the most famous tumor suppressors and the most frequently inactivated in a variety of hunman cancers. Through its transcriptional activity, p53 is involved in various stress responses and phentotypes, such as DNA damage response, cell death, and cellular senescence. In addition, recent studies have revealed p53 functions in energy metabolism, antioxidant function, and intracellular metabolic reprogramming. These physiological functions can be demonstrated by the diversity of functions of a huge number of p53 target genes. Furthermore, the new functions of p53 have been elucidated by integrating transcriptome analysis with the latest genome analysis technologies, such as next-generation sequencing and metabolomics analysis. Thus, it is still necessary to elucidate the physiological function of p53, which continues to expand. Here, we welcome papers describing original research and review articles to understand the role of p53 function in cell fate decisions and various diseases, including cancer.

Prof. Kiyotsugu Yoshida
Prof. Hidetoshi Hayashi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • angiogenesis
  • apoptosis
  • autophagy
  • cancer
  • cell cycle
  • cell death
  • cellular stress
  • DNA damage
  • DNA repair
  • drug sensitivity
  • genome stability
  • metabolism
  • molecular target drugs
  • p53
  • senescence
  • stemness

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 5310 KiB  
Article
Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence
by Chiharu Miyajima, Yuki Kawarada, Yasumichi Inoue, Chiaki Suzuki, Kana Mitamura, Daisuke Morishita, Nobumichi Ohoka, Takeshi Imamura and Hidetoshi Hayashi
Cells 2020, 9(1), 171; https://doi.org/10.3390/cells9010171 - 9 Jan 2020
Cited by 18 | Viewed by 4746
Abstract
Transcriptional coactivator with a PDZ-binding motif (TAZ) is one of the mammalian orthologs of Drosophila Yorkie, a transcriptional coactivator of the Hippo pathway. TAZ has been suggested to function as a regulator that modulates the expression of cell proliferation and anti-apoptotic genes in [...] Read more.
Transcriptional coactivator with a PDZ-binding motif (TAZ) is one of the mammalian orthologs of Drosophila Yorkie, a transcriptional coactivator of the Hippo pathway. TAZ has been suggested to function as a regulator that modulates the expression of cell proliferation and anti-apoptotic genes in order to stimulate cell proliferation. TAZ has also been associated with a poor prognosis in several cancers, including breast cancer. However, the physiological role of TAZ in tumorigenesis remains unclear. We herein demonstrated that TAZ negatively regulated the activity of the tumor suppressor p53. The overexpression of TAZ down-regulated p53 transcriptional activity and its downstream gene expression. In contrast, TAZ knockdown up-regulated p21 expression induced by p53 activation. Regarding the underlying mechanism, TAZ inhibited the interaction between p53 and p300 and suppressed the p300-mediated acetylation of p53. Furthermore, TAZ knockdown induced cellular senescence in a p53-dependent manner. These results suggest that TAZ negatively regulates the tumor suppressor functions of p53 and attenuates p53-mediated cellular senescence. Full article
(This article belongs to the Special Issue Role of p53 in Cell Death and Cancers)
Show Figures

Figure 1

Back to TopTop